Nov 18, 2019 / 01:30PM GMT
Operator
Thank you for standing by. This is the conference operator. Welcome to the Resverlogix Conference Call and Webcast to present detailed preliminary results on BETonMACE.
(Operator Instructions) And the conference is being recorded. (Operator Instructions] I would now like to turn the conference over to Mr. Donald McCaffrey, President and Chief Executive Officer of Resverlogix Corp.
Please go ahead.
Donald J. McCaffrey - Resverlogix Corp. - Co-Founder, Chairman, President, CEO & Secretary
Good morning, ladies and gentlemen. This is Don McCaffrey. I'm the President and CEO of Resverlogix, and it's a great pleasure to be here today to be giving some additional updates on our drug development program.
I will start today by reviewing the executive summary of what will be covered. But first, I'd like to comment on our late-breaker presentation that happened at the American Heart Association on Saturday. It went exceptionally well with over 3,000 people in attendance, leaving the session believing that with little more work, we have a
Resverlogix Corp. - Special Call Transcript
Nov 18, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers